Answer
Ultomiris (ravulizumab) 300 mg/3 mL and 1100 mg/11 mL concentrate for solution for infusion should not be shaken during dilution; it should be mixed gently.
Sources for this answer
- Ultomiris 300 mg/3 mL and 1100 mg/11 mL PLGB 31187/0007Alexion Pharma UK Ltd · emc · SmPC §6.6 Special precautions for disposal and other handling · Version 12Document updated
Sources checked